Human LIGHT/TNFSF14 APC-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB664A
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Asp74-Val240
Accession # O43557
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human LIGHT/TNFSF14 APC-conjugated Antibody
Detection of LIGHT/TNFSF14 in PBMC treated with PMA and Calcium Ionomycin vs resting PBMC by Flow Cytometry
PBMC treated with 50ng/mL PMA and 500ng/mL Calcium Ionomycin for 48 hours (A) vs resting PBMC (B) were stained with Mouse Anti-Human LIGHT/TNFSF14 APC-conjugated Monoclonal Antibody (Catalog # FAB664A) and Mouse Anti-Human CD8 alpha PE-conjugated Monoclonal Antibody (Catalog # FAB1509P) isotype control antibody (Catalog # IC002A). View our protocol for Staining Membrane-associated Proteins.Applications for Human LIGHT/TNFSF14 APC-conjugated Antibody
Flow Cytometry
Sample: Human PBMC treated with PMA and Calcium Ionomycin
Spectra Viewer
Plan Your Experiments
Use our spectra viewer to interactively plan your experiments, assessing multiplexing options. View the excitation and emission spectra for our fluorescent dye range and other commonly used dyes.
Spectra ViewerFormulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: LIGHT/TNFSF14
Human LIGHT, also known as TNFSF14, is a type II membrane protein that is a member of the TNF superfamily. LIGHT is an acronym which stands for "is homologous to Lymphotoxins, exhibits Inducible expression, and competes with HSV Glycoprotein D for HVEM, a receptor expressed by T lymphocytes". LIGHT has also been called HVEM-L and LT-gamma. LIGHT is a 240 amino acid (aa) protein that contains a 37 aa cytoplasmic domain, a 22 aa transmembrane region, and a 181 aa extracellular domain. Similar to other TNF ligand family members, LIGHT is predicted to assemble as a homotrimer. LIGHT is produced by activated T cells and was first identified by its ability to compete with HSV glycoprotein D for HVEM binding. LIGHT has also been shown to bind to the Lymphotoxin beta Receptor (LT betaR) and the decoy receptor, DcR3/TR6. LIGHT overexpression in tumor cells induces apoptosis, which can be enhanced by IFN-gamma.
References
- Mauri, D.N. et al. (1998) Immunity 8:21.
- Zhai, Y. et al. (1998) J. Clin. Invest. 102:1142.
- Harrop, J.A. et al. (1998) J. Biol. Chem. 273:27548.
- Yu, K-Y. et al. (1999) J. Biol. Chem. 274:13733.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional LIGHT/TNFSF14 Products
Product Documents for Human LIGHT/TNFSF14 APC-conjugated Antibody
Product Specific Notices for Human LIGHT/TNFSF14 APC-conjugated Antibody
For research use only